In this online, self-learning activity:
Mesothelioma is a malignancy that occurs in mesothelium, an epithelial layer that lines the pleurae, peritoneum, pericardium, the testes’ tunica vaginalis and tunica serosa uteri. Malignant mesothelioma (MM) may occur in any area that is composed of mesothelial cells, but the most common site is in the pleural space (81%) in cases of malignant pleural mesothelioma (MPM), followed by peritoneum (9%).. In United States, approximately 3,200 new cases of MM are diagnosed each year, and it mostly affects older white male with median age of 62 at diagnosis for MPM and a slightly younger median age for peritoneal MM. Whites are twice as likely to develop MM as blacks, and males are four times as likely as females. The largest risk factor for MM is a history of asbestos exposure: over 80% of MPM patients and 33% of patients with peritoneal MM have a documented prior exposure.
Healthcare professionals including: medical oncologists, primary care physicians, and pathologists; physicians assistants, nurse practitioners, nurses, and pharmacists specializing in oncology; and other clinicians who are involved in providing diagnostic and therapeutic services for patients with mesothelioma.
This program is supported by educational grants from Novacure.
This activity is free of charge.
Release Date: June 15, 2021 -- Expiration Date: June 15, 2023
Faculty: Robert Cameron, MD
Epidemiology, risk factors, and different types of mesothelioma
Diagnosis and treatment of mesothelioma
By the end of the session the participant will be able to:
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Robert Cameron, MD, discloses that he is a stockholder in Volition Rx LTD and on a scientific advisory board for Novocure.
Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, has no relevant financial disclosures.
Commercial Support Disclosure: This program is supported by educational grants from Novocure.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.